Literature DB >> 25922276

Mechanisms of unconventional secretion of IL-1 family cytokines.

Mercedes Monteleone1, Jennifer L Stow1, Kate Schroder2.   

Abstract

One of the most poorly understood processes in cell biology is the peculiar ability of specific leaderless proteins to be secreted via ER/Golgi-independent mechanisms ('unconventional protein secretion'). One such leaderless protein is the major immune-activating cytokine, interleukin-1β (IL-1β). Unusual amongst cytokines, IL-1β is expressed in the cytosol as an inactive precursor protein. It requires maturation by the caspase-1 protease, which itself requires activation upon immune cell sensing of infection or cell stress. Despite 25 years of intensive research into IL-1β secretory mechanisms, how it exits the cell is still not well understood. Here we will review the various mechanisms by which macrophages have been proposed to secrete IL-1 family cytokines, and the potential involvement of caspase-1 therein. Since aberrant IL-1β production drives inherited and acquired human diseases (e.g. autoinflammatory diseases, arthritic diseases, gout, Alzheimer's disease), elucidation of the IL-1β secretory pathway may offer new therapeutic opportunities for treatment across this wide range of human conditions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Caspase-1; Inflammasome; Interleukin-1; Unconventional secretion

Mesh:

Substances:

Year:  2015        PMID: 25922276     DOI: 10.1016/j.cyto.2015.03.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  46 in total

1.  Gasdermin D-independent release of interleukin-1β by living macrophages in response to mycoplasmal lipoproteins and lipopeptides.

Authors:  Ayumi Saeki; Kohsuke Tsuchiya; Takashi Suda; Takeshi Into; Akira Hasebe; Toshihiko Suzuki; Ken-Ichiro Shibata
Journal:  Immunology       Date:  2020-07-23       Impact factor: 7.397

2.  Not your usual tRNA synthetase: hWARS serves as an enterovirus entry factor.

Authors:  Stanley Perlman; Tom Gallagher
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 14.808

Review 3.  Autophagy-dependent secretion: mechanism, factors secreted, and disease implications.

Authors:  Jacob New; Sufi Mary Thomas
Journal:  Autophagy       Date:  2019-04-14       Impact factor: 16.016

4.  Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion.

Authors:  S A Conos; K E Lawlor; D L Vaux; J E Vince; L M Lindqvist
Journal:  Cell Death Differ       Date:  2016-07-15       Impact factor: 15.828

Review 5.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

Review 6.  Inflammasomes: mechanism of assembly, regulation and signalling.

Authors:  Petr Broz; Vishva M Dixit
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

7.  Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.

Authors:  Muhammad Zahoor; Marita Westhrin; Kristin Roseth Aass; Siv Helen Moen; Kristine Misund; Katarzyna Maria Psonka-Antonczyk; Mariaserena Giliberto; Glenn Buene; Anders Sundan; Anders Waage; Anne-Marit Sponaas; Therese Standal
Journal:  Blood Adv       Date:  2017-12-13

8.  Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus.

Authors:  Devin P Champagne; Ketki M Hatle; Karen A Fortner; Angelo D'Alessandro; Tina M Thornton; Rui Yang; Daniel Torralba; Julen Tomás-Cortázar; Yong Woong Jun; Kyo Han Ahn; Kirk C Hansen; Laura Haynes; Juan Anguita; Mercedes Rincon
Journal:  Immunity       Date:  2016-05-24       Impact factor: 31.745

Review 9.  The intersection of cell death and inflammasome activation.

Authors:  James E Vince; John Silke
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

Review 10.  [Caspase-1 regulates autoinflammation in rheumatic diseases].

Authors:  S Winkler; C M Hedrich; A Rösen-Wolff
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.